PALI
PALI
US6963894026
Palisade Bio, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
268.38M EUR
363.23M EUR
293.34M EUR
375.16M EUR
Enterprise Value
127.52M EUR
238.06M EUR
160.71M EUR
241.85M EUR
Valuation Multiples
Trailing P/E
2.57x
--
--
--
Forward P/E
-5.43x
--
--
--
Price to Sales
536.75x
726.46x
--
--
Price to Book
2.2x
2.98x
2.3x
2.9x
EV/Revenue
255.05x
476.12x
--
--
EV/EBITDA
-3.61x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-3.22%
-5.01%
-4.23%
-2.27%
ende